Schedule 13G ownership disclosure

Climb Bio, Inc.

Common Stock, par value $0.0001 per share · CUSIP: 28658R106

Event date: 2024-06-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Pontifax VI G.P. L.P.

    Shares: 5,206,380.00 · Class: 7.7%

  • Pontifax Management 4 G.P. (2015) Ltd.

    Shares: 5,206,380.00 · Class: 7.7%

  • Ran Nussbaum

    Shares: 5,206,380.00 · Class: 7.7%

  • Tomer Kariv

    Shares: 5,206,380.00 · Class: 7.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-088802
Form type
SCHEDULE 13G
Filer
Climb Bio, Inc.
CIK
CIK 1768446
Filed
Sep 18, 2025
Reporting period
Jun 27, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub